2874
D. Enders et al.
LETTER
solution was stirred for 1 h, after which the Michael acceptor
2 (1.0 mmol in 1 mL dry THF) was added dropwise. The
mixture was stirred for 4–6 h at –90 °C to – 95 °C. The
progress of the reaction was monitored by TLC. The mixture
was quenched with sat. NH4Cl (3 mL). After separation of
the organic layer, the aqueous phase was extracted with
CH2Cl2 (4 × 5 mL). The combined organic layers were dried
over MgSO4, evaporated, and the crude product was purified
by flash column chromatography (silica gel, Et2O–pentane,
1:2) to afford 3a–j.
Dimethyl 2-(2-{5-(2,2-dimethyl-1,3-dioxolan-4-yl)-2,2-
dimethyltetrahydrofuro[2,3-d][1,3]dioxol-6-yloxy-
sulfonyl}-2-phenyl-1-p-tolylethyl)malonate (3b)
Yield 454 mg (70%); colorless solid; ds = 73%; the major
diastereomer was separated by preparative HPLC; de 98%;
mp 66–68 °C. 1H NMR (400 MHz, CDCl3): d = 1.32, 1.36,
1.37, 1.70 [4 × s, 12 H, (O)2C(CH3)2], 2.32 (s, 3 H, CH3),
3.33 (dd, J = 7.4, 8.5 Hz, 1 H, CHHOC), 3.44, 3.52 (2 × s, 6
H, OCH3), 3.72 (dd, J = 7.0, 8.5 Hz, 1 H, CHHOC), 3.76 [dd,
J = 2.5, 8.8 Hz, 1 H, CH(OC)CH(OC)CH2O], 3.81 [d,
J = 7.1 Hz, 1 H, CH(CO2)2], 4.13 [dt, J = 2.5, 7.0 Hz, 1 H,
CH(OC)CH2O], 4.20–4.26 [m, 2 H, CH(OC)CH(OC)2,
CHCH(CO2)2], 4.47 (dd, J = 4.7, 8.8 Hz, 1 H, CHOSO2),
5.60 (d, J = 9.6 Hz, 1 H, PhCHSO3), 5.64 [d, J = 3.6 Hz, 1
H, CH(OC)2], 7.11 (d, J = 8.0 Hz, 2 H, ArH), 7.38–7.46 (m,
7 H, ArH). 13C NMR (100 MHz, CDCl3): d = 21.1 (CH3),
25.3, 25.9, 26.4, 26.6 [O2C(CH3)2], 47.5 [CHCH(CO2)2],
52.1, 52.3 (OCH3), 54.7 [CH(CO2)2], 64.1 (CH2), 70.7
(PhCHSO3), 73.7 [CH(OC)CH2O], 76.0
Acknowledgment
This work was supported by the Fonds der Chemischen Industrie.
Z.M. and H.S. thank the Ministry of Science of Iran and the DAAD
for a scholarship. We thank BASF AG for the donation of chemi-
cals.
References and Notes
(1) (a) Kalir, A.; Kalir, H. H. In The Chemistry of Sulfonic
Acids, Esters and their Derivatives; Patai, S.; Rappoport, Z.,
Eds.; Wiley: New York, 1991, 767. (b) Yoshikawa, M.;
Yamaguchi, S.; Kunimi, K.; Matsuda, H.; Kuno, Y.;
Yamahara, J.; Murakami, N. Chem. Pharm. Bull. 1994, 42,
1226. (c) Ovenden, S. P. B.; Capon, R. J. J. Nat. Prod. 1999,
62, 1246. (d) Minami, I.; Akimoto, H.; Kondo, M.; Nomura,
H. Chem. Pharm. Bull. 1983, 42, 482. (e) Dickson, J. K.;
Biller, S. A.; Magnin, D. R.; Petrillo, E. W. Jr.; Hillyer, J.
W.; Hsieh, D. C.; Lan, S.; Rinehart, J. K.; Gregg, R. E.;
Harrity, T. W.; Jolibois, K. G.; Kalinoski, S. S.;
Kunselmann, L. K.; Mookhtiar, K. A.; Ciosek, C. P. Jr.
J. Med. Chem. 1996, 39, 661. (f) Morimoto, S.;Nomura, H.;
Ishiguro, T.; Fugono, T.; Maeda, K. J. Med. Chem. 1972, 15,
1105.
(2) (a) Xie, M.; Widlanski, T. S. Tetrahedron Lett. 1996, 37,
4443. (b) Huang, J.; Widlanski, T. S. Tetrahedron Lett.
1992, 33, 2657.
(3) (a) Lawrence, R. M.; Biller, S. A.; Dickson, J. K.; Logan,
J. V. H.; Mignin, D. R.; Sulsky, R. B.; DiMarco, J. D.;
Gougoutas, J. Z.; Beyer, B. D.; Taylor, S. C.; Lan, S.;
Ciosek, C. P.; Harrity, T. W.; Jolibois, K. G.; Kunselman, L.
K.; Slusarchyk, D. A. J. Am. Chem. Soc. 1996, 118, 11668.
(b) Corey, E. J.; Cimprich, K. A. Tetrahedron Lett. 1992, 33,
4099.
(4) (a) Enders, D.; Vignola, N.; Berner, O. M. Angew. Chem.
Int. Ed. 2002, 41, 109. (b) Enders, D.; Berner, O. M.;
Vignola, N.; Bats, J. W. Chem. Commun. 2001, 2498.
(c) Enders, D.; Berner, O. M.; Vignola, N.; Harnying, W.
Synthesis 2002, 1945. (d) Enders, D.; Harnying, W.;
Vignola, N. Synlett 2002, 1727. (e) Enders, D.; Harnying,
W.; Vignola, N. Eur. J. Org. Chem. 2003, 3939. (f) Enders,
D.; Harnying, W. Synthesis 2004, 2910. (g) Enders, D.;
Harnying, W. ARKIVOC 2004, (ii), 181. (h) Enders, D.;
Harnying, W.; Raabe, G. Synthesis 2004, 590. (i) Enders,
D.; Adelbrecht, J.-C.; Harnying, W. Synthesis 2005, 2962.
(j) Harnying, W.; Kitisriworaphan, W.; Pohmakotr, M.;
Enders, D. Synlett 2007, 2529. (k) Enders, D.; Iffland, D.
Synthesis 2007, 1837. (l) Enders, D.; Iffland, D.; Raabe, G.
Synthesis 2009, 1683.
(5) (a) Murray, R. D. H.; Mendez, J.; Brown, S. A. The Natural
Coumarins: Occurrence, Chemistry and Biochemistry;
Wiley: New York, 1982. (b) Zabradink, M. The Production
and Application of Fluorescent Brightening Agents; Wiley:
New York, 1992. (c) Yu, D.; Xie, M. L.; Morris-Natschke,
S. L.; Lee, K. H. Med. Res. Rev. 2003, 23, 322. (d) Wang,
C. J.; Hsieh, Y. J.; Chu, C. Y.; LinY, L.; Tseng, T. H. Cancer
Lett. 2002, 183, 163.
[CH(OC)CH(OC)CH2O], 76.6 [CH(OC)CH(OC)2], 76.9
(CHOSO2), 103.2 [CH(OC)2], 109.7, 113.2 [(O)2C(CH3)2],
128.2, 128.7, 129.2, 129.9, 130.2 (ArCH), 131.4, 132.7,
137.3 (ArC), 167.5, 167.9 (CO2). IR (KBr): 2954, 2986,
1736, 1602, 1516, 1436, 1370, 1163, 1017, 931, 833, 701
cm–1. MS (EI, 70 eV): m/z (%) = 633.6 (10) [M+ – CH3],
261.3 (37), 235.3 (66), 205.3 (40), 169.2 (89), 135.3 (100),
127.3 (66). Anal. Calcd for C32H40O12S (648.6): C, 59.25; H,
6.21. Found: C, 59.13; H, 6.12.
General Procedure for the Removal of the Chiral
Auxiliary
The sulfonate 3b (0.5 mmol) was dissolved in a solution of
2% TFA in MeOH–H2O (10:1 mL). The solution was
refluxed for 15 h and then evaporated to dryness. The
resulting oil was dissolved in CH2Cl2, (i-PrO)3CH (5 mmol)
was added dropwise, and the mixture was refluxed for 3 h.
The solvent was removed in vacuo, and the crude product
was purified by flash column chromatography (SiO2, Et2O–
pentane, 1:3) to yield the final product 6.
Dimethyl 2-[2-(Isopropoxysulfonyl)-2-phenyl-1-p-
tolylethyl]malonate (6)
Yield 107 mg (48%); colorless solid; mp 72–74 °C; de and
ee 98% (HPLC); [a]D22 +52.24 (c 0.67, CHCl3). 1H NMR
(400 MHz, CDCl3): d = 0.89, 1.03 [2 × d, J = 6.0 Hz, 6 H,
(CH3)2CH], 2.32 (s, 3 H, CH3), 3.42, 3.54 (2 × s, 6 H,
OCH3), 3.95 [d, J = 8.0 Hz, 1 H, CH(CO2)2], 4.19 [dd,
J = 8.0, 9.1 Hz, 1 H, CHCH(CO2)2], 4.47 (sept, J = 6.0 Hz, 1
H, CHOSO2), 5.13 (d, J = 9.1 Hz, 1 H, PhCHSO3), 7.10 (d,
J = 8.0 Hz, 2 H, ArH), 7.30–7.42 (m, 7 H, ArH). 13C NMR
(100 MHz, CDCl3): d = 21.2 (CH3), 22.3, 23.1 [(CH3)2CH],
47.4 [CHCH(CO2)2], 52.3, 52.6 (OCH3), 55.1 [CH(CO2)2],
70.0 (CHSO3), 77.9 (CHOSO2), 128.6, 128.6, 129.0, 130.0,
130.1 (ArCH), 132.3, 132.7, 137.5 (ArC), 167.8, 168.2
(CO2). IR (KBr): 2987, 2954, 1738, 1596, 1436, 1370, 1213,
1165, 1017, 871, 840, 698 cm–1. MS (EI, 70 eV): m/z
(%) = 448.2 (5.7) [M+], 235.2 (43), 205.2 (21), 135.1 (100).
Anal. Calcd for C23H28O7S (448.2): C, 61.59; H, 6.29.
Found: C, 61.31; H, 6.78. HRMS: m/z calcd for C23H28O7S:
448.1550; found: 448.1552.
(6) CCDC-739752 (3i) contains the supplementary
crystallographic data for this paper. These data can be
obtained free of charge from the Cambridge Crystallo-
cif.
(7) General Procedure for the Synthesis of a,b-Disubstituted
g-Alkoxycarbonyl Sulfonates 3a–j
To a solution of enantiopure sulfonate 1 (1.0 mmol) in dry
THF (10 mL), n-BuLi (1.6 M solution in hexane, 0.63 mL)
was added dropwise at –90 °C to – 95 °C under argon. The
Synlett 2009, No. 17, 2872–2874 © Thieme Stuttgart · New York